Highlighting the value of polymyography in childhood onset movement disorders - Top-Institutions - MDSpire

Highlighting the value of polymyography in childhood onset movement disorders

  • By

  • Raffaella Moretti

  • Claudia Ravelli

  • Yara Ahmar

  • Nathalie Dorison

  • Marie De Salins

  • Diana Rodriguez

  • Kumaran Deiva

  • Anne Isabelle Vermersch

  • Minh Hanh Triboulet

  • Stéphanie Valence

  • Madeleine Harion

  • Lydie Burglen

  • Emmanuelle Apartis

  • Diane Doummar

  • May 28, 2026

  • 0 min

Share

Top Institutions in Neurology

Brief introduction explaining scope and methodology.

  • #1

    Reference Centre for Paediatric Movement Disorders
    Reference Centre for Paediatric Movement Disorders

    Unknown, Unknown

    Key Differentiators

    • Neurology

  • #2

    paediatric neurophysiology department
    paediatric neurophysiology department

    Unknown, Unknown

    Key Differentiators

    • Neurology

  • #3

    Rothschild Foundation Hospital
    Rothschild Foundation Hospital

    Unknown, Unknown

    Key Differentiators

    • Pediatric Neurology

  • #4

    Xiamen Children's Hospital
    Xiamen Children's Hospital

    Xiamen, Fujian

    Key Differentiators

    • Pediatric Neurology

  • #5

    University Hospital Schleswig-Holstein
    University Hospital Schleswig-Holstein

    Lübeck, Schleswig-Holstein

    Key Differentiators

    • Neurology

Original Source(s)

Highlighting the value of polymyography in childhood onset movement disorders

  • by Raffaella Moretti, Claudia Ravelli, Yara Ahmar, Nathalie Dorison, Marie De Salins, Diana Rodriguez, Kumaran Deiva, Anne Isabelle Vermersch, Minh Hanh Triboulet, Stéphanie Valence, Madeleine Harion, Lydie Burglen, Emmanuelle Apartis, Diane Doummar

  • May 28, 2026

Related Content

Low Follow-Up After Behavioral ED Care

Follow-up occurred after fewer than 15% of mental health ED visits and about 11% of substance use–related visits in Washington Medicaid claims.

Incidental Findings Common on Whole-Body Trauma CT

Findings prompted follow-up, workup, or treatment in about 30% of patients, but estimates varied widely

Semaglutide Tested in Alcohol Use Disorder

Randomized trial found improvements in alcohol consumption and metabolic outcomes, with gastrointestinal adverse events more common with treatment